Literature DB >> 12554095

Exosite-dependent regulation of the protein C anticoagulant pathway.

Alireza R Rezaie1.   

Abstract

Activated protein C (APC) is a vitamin K-dependent anticoagulant serine protease in plasma that downregulates the coagulation cascade by degrading cofactors Va and VIIIa by limited proteolysis. In addition to its anticoagulant function, APC also exhibits potent profibrinolytic and anti-inflammatory properties. The proteolytic activity of APC in plasma is slowly inhibited by three serpins: protein C inhibitor, plasminogen activator inhibitor-1, and alpha(1)-antitrypsin. Recent structural and mutagenesis data have indicated that basic residues of three exposed surface loops known as the 39-loop (Lys(37)-Lys(39)), 60-loop (Lys(62), Lys(63)), and 70-80-loop (Arg(74), Arg(75), and Lys(78)) (chymotrypsin numbering) constitute an anion-binding exosite in APC that interacts with these macromolecular substrates and inhibitors. Moreover, this exosite plays a critical role in the thrombomodulin-dependent activation of the zymogen protein C by thrombin. This article briefly reviews how the binding of physiological protein and polysaccharide cofactors on this exosite modulates the protein C anticoagulant pathway in plasma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554095     DOI: 10.1016/s1050-1738(02)00191-3

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  9 in total

1.  Paclitaxel induces thrombomodulin downregulation in human aortic endothelial cells.

Authors:  Huang-Joe Wang; Te-Ling Lu; Haimei Huang; Huey-Chun Huang
Journal:  Tex Heart Inst J       Date:  2011

2.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

Review 3.  Protein C anticoagulant and cytoprotective pathways.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Int J Hematol       Date:  2012-04-05       Impact factor: 2.490

4.  Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.

Authors:  R Costa; A Morrison; J Wang; C Manithody; J Li; A R Rezaie
Journal:  J Thromb Haemost       Date:  2012-09       Impact factor: 5.824

Review 5.  Regulation of the protein C anticoagulant and antiinflammatory pathways.

Authors:  A R Rezaie
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

6.  Activated protein C: a potential cardioprotective factor against ischemic injury during ischemia/reperfusion.

Authors:  Jingying Wang; Ji Li
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

7.  Down-regulation of the clotting cascade by the protein C pathway.

Authors:  Fabian Stavenuiter; Eveline A M Bouwens; Laurent O Mosnier
Journal:  Hematol Educ       Date:  2013

8.  Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke.

Authors:  Shaheen E Lakhan; Annette Kirchgessner; Deborah Tepper; Aidan Leonard
Journal:  Front Neurol       Date:  2013-04-03       Impact factor: 4.003

9.  Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia.

Authors:  Xiao-Yan Zhao; Andreas Wilmen; Dongli Wang; Xinquan Wang; Maxine Bauzon; Ji-Yun Kim; Lars Linden; Liang Li; Ursula Egner; Tobias Marquardt; Dieter Moosmayer; Jan Tebbe; Julian Marius Glück; Philipp Ellinger; Kirk McLean; Shujun Yuan; Subramanian Yegneswaran; Xiaoqiao Jiang; Vince Evans; Jian-Ming Gu; Doug Schneider; Ying Zhu; Yifan Xu; Cornell Mallari; Ashley Hesslein; Yan Wang; Nicole Schmidt; Katrin Gutberlet; Christine Ruehl-Fehlert; Alexius Freyberger; Terry Hermiston; Chandra Patel; Derek Sim; Laurent O Mosnier; Volker Laux
Journal:  Nat Commun       Date:  2020-06-12       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.